Soft Tissue Sarcomas
Surgery recommended for treating adult head and neck soft tissue sarcomas
Published in Cancer Weekly, December 6th, 2005
According to recent research from the United States, "The purpose was to determine the optimal treatment for adult patients with head and neck soft tissue sarcomas. We conducted a review of the pertinent literature. Local control after surgery alone or combined with radiotherapy was obtained in approximately 60% to 70% of the patients."
"The probability of local control is influenced by histologic grade, tumor size, and surgical margins. Patients with high-grade tumors and/or positive margins have improved local control if adjuvant radiotherapy is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-12-06)
More Articles from Cancer Weekly
- Adverse Drug Reaction
Adverse drug reactions might occur during lymphatic mapping and sentinel lymph node biopsy - Apoptosis
Inhibition of JAK3/STAT3 signaling induced apoptosis of colon carcinoma cells - Carcinogenesis
Aluminium, a component of antiperspirants, implicated in breast cancer - Surgery
Improved long-term survival linked to resection at high-volume cancer centers - Acute Myeloid Leukemia
Clofarabine's duration of response improves outcome for elderly AML patients - Acute Myeloid Leukemia
Gefitinib induces myeloid differentiation of acute myeloid leukemia - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
